FindTrial
Sign In

The sedative effect of propofol combined with nalbuphine in gastroscopy: a retrospective study protocol

Comparision of propofol alone and propofol with nalbuphine for sedation on gastroscopy: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035276
Enrollment
Unknown
Registered
2020-08-06
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early cancer screening

Interventions

nalbuphine group:propofol combined with nalbuphine
propofol group:propofol alone

Sponsors

Zhongshan Hospital Affiliated to Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I - II patients; 2. Patients aged 18-65 years; 3. Cases of gastroscopy with propofol alone or with propofol combined with nalbuphine for deep sedation.

Exclusion criteria

Exclusion criteria: 1. Propofol combined with other opioids for sedation; 2. Patients with incomplete case records; 3. Patients who are allergic to the study drug; 4. Patients with sleep apnea syndrome; 5. Patients with severe liver and kidney diseases.

Design outcomes

Primary

MeasureTime frame
blood pressure;Heart rate;Blood oxygen saturation;Body movement frequency and classification;Cough frequency, time period and grade;—

Countries

China

Contacts

Public ContactZhongxin Shao

Department of Anesthesiology, Zhongshan Hospital, Xiamen University

rogers6666@163.com+86 15750737037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026